---
figid: PMC4120074__nihms602377f7
figlink: /pmc/articles/PMC4120074/figure/F7/
number: Figure 7
caption: Vemurafenib treatment relieves a negative feedback on ERBB3 transcription
  resulting in an increase of ERBB3 at the membrane. In the presence of its ligand,
  NRG1, ERBB3 heterodimerizes with ERBB2 to become active. Active ERBB3 recruits PI3K,
  which signals to the AKT pathway promoting survival of mutant BRAF melanoma cells
  treated with vemurafenib. Treatment with the anti-ERBB3 monoclonal antibody huHER3-8
  outcompetes NRG1 and prevents the activation of ERBB3 and AKT signaling and enhances
  the efficacy of vemurafenib treatment.
pmcid: PMC4120074
papertitle: Function-blocking ERBB3 antibody inhibits the adaptive response to RAF
  inhibitor.
reftext: Curtis H. Kugel, et al. Cancer Res. ;74(15):4122-4132.
pmc_ranked_result_index: '22312'
pathway_score: 0.9740184
filename: nihms602377f7.jpg
figtitle: Function-blocking ERBB3 antibody inhibits the adaptive response to RAF inhibitor
year: ''
organisms: Homo sapiens
ndex: 6ecf073b-dec0-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4120074__nihms602377f7.html
  '@type': Dataset
  description: Vemurafenib treatment relieves a negative feedback on ERBB3 transcription
    resulting in an increase of ERBB3 at the membrane. In the presence of its ligand,
    NRG1, ERBB3 heterodimerizes with ERBB2 to become active. Active ERBB3 recruits
    PI3K, which signals to the AKT pathway promoting survival of mutant BRAF melanoma
    cells treated with vemurafenib. Treatment with the anti-ERBB3 monoclonal antibody
    huHER3-8 outcompetes NRG1 and prevents the activation of ERBB3 and AKT signaling
    and enhances the efficacy of vemurafenib treatment.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PIK3R4
  - PIK3CD
  - AKT2
  - PIK3CA
  - PIK3R5
  - MAPK1
  - PIK3CB
  - PIK3CG
  - AKT1
  - PIK3R6
  - ERBB3
  - MAPK3
  - AKT3
  - ERBB2
  - NRG1
  - PIK3R3
  - BRAF
genes:
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: ERBB3
  symbol: ERBB3
  source: hgnc_symbol
  hgnc_symbol: ERBB3
  entrez: '2065'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: ERBB2
  symbol: ERBB2
  source: hgnc_symbol
  hgnc_symbol: ERBB2
  entrez: '2064'
- word: NRG1
  symbol: NRG1
  source: hgnc_symbol
  hgnc_symbol: NRG1
  entrez: '3084'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: BRAF
  symbol: BRAF
  source: hgnc_symbol
  hgnc_symbol: BRAF
  entrez: '673'
chemicals: []
diseases: []
---
